IRulya Therapeutics QNCX
NASDAQ QNCX
$40.27 +5.82 (+16.89%)
At close: Oct 20, 2026 · 4:00 PM EDT

Quince Therapeutics, Inc. (QNCX) Non-Current Deferred Tax Liability (2022 - 2025)

Updated

IRulya Therapeutics (QNCX) reported Non-Current Deferred Tax Liability of $5.59 million for Q3 2025, up 3.9% from $5.38 million a year earlier and unchanged from the prior quarter.

Analysis

Quince Therapeutics, Inc. (QNCX) Non-Current Deferred Tax Liability (2022 - 2025) Analysis & Trends

At the end of FY2024, IRulya Therapeutics posted Non-Current Deferred Tax Liability of $4.96 million, down 6.4% from FY2023.

  • By year, Non-Current Deferred Tax Liability came in at $5.3 million in FY2023 and $248,000 in FY2022.
  • Five-year quarterly Non-Current Deferred Tax Liability spans a low of $248,000 in Q2 2022 and a high of $5.6 million in Q2 2025.
  • Year over year, Non-Current Deferred Tax Liability gained in two of the last four quarters, with growth averaging 1.4%.
  • Per Business Quant data, the three quarters before Q3 2025 came in at $5.6 million (Q2 2025), $5.17 million (Q1 2025) and $4.96 million (Q4 2024).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 5.59 Mn
Jun 30, 2025 5.60 Mn
Mar 31, 2025 5.17 Mn
Dec 31, 2024 4.96 Mn
Sep 30, 2024 5.38 Mn
Jun 30, 2024 5.17 Mn
Mar 31, 2024 5.18 Mn
Dec 31, 2023 5.30 Mn
Dec 31, 2022 248,000.00
Sep 30, 2022 248,000.00
Jun 30, 2022 248,000.00
API Access

Quince Therapeutics, Inc. Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=QNCX&period=max&api_key=YOUR_API_KEY